Surgical Wound Infection

1
Pipeline Programs
3
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
1
Amicidin-β topical solution - 15 mLPhase 11 trial
Active Trials
NCT07379684Recruiting44Est. Oct 2026
Pacific Science
Pacific ScienceCA - Torrance
1 program
SafeHaven Automated Hand Hygiene DeviceN/A1 trial
Active Trials
NCT04900298RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Novo NordiskAmicidin-β topical solution - 15 mL
Pacific ScienceSafeHaven Automated Hand Hygiene Device

Clinical Trials (2)

Total enrollment: 44 patients across 2 trials

NCT07379684Novo NordiskAmicidin-β topical solution - 15 mL

A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections

Start: Feb 2026Est. completion: Oct 202644 patients
Phase 1Recruiting
NCT04900298Pacific ScienceSafeHaven Automated Hand Hygiene Device

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

Start: Jan 2022Est. completion: Jun 2026
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 44 patients
3 companies competing in this space